Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Piia Lavikainen

Biographic Data

ID9223415
NAMEPiia Lavikainen
GIVEN NAMESPiia
FAMILY NAMELavikainen
SIGNATURELAVIKAINEN P
AFFILIATIONSUniversity of Eastern Finland
ORCID0000-0003-3560-8860
VERIFIEDYes
TOTAL WORKS2
TOTAL CITATIONS0
WORKS AS AUTHOR2
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2020
LATEST PUBLICATION YEAR2026
H-INDEX0
  • Normative values for paid and unpaid work productivity for estimating productivity-adjusted life expectancy in Finland

    Open Access•Piia Lavikainen, Jari Heiskanen et al.•ARTICLE•Social Science & Medicine•2026

    BACKGROUND: Normative regional estimates of productivity are essential for deriving reliable predictions of productivity-adjusted life expectancy (PALE). This study aimed to establish Finnish population norms for health-related productivity by estimating age- and sex-specific norms for paid and unpaid work productivity indices, as well as combined weighted productivity index. Using national life expectancy data, corresponding PALE values were als…

  • Short-term impact of co-payment level increase on the use of medication and patient-reported outcomes in Finnish patients with type 2 diabetes

    Open Access•Piia Lavikainen, Emma Aarnio et al.•ARTICLE•Health Policy•2020

    A new reimbursement scheme for non-insulin medications used for treatment of hyperglycemia in type 2 diabetes (T2D) was implemented in Finland on January 1, 2017. The aim of the study was to evaluate the impact of this co-payment increase (i.e. + 35 percentage points) on patient-reported satisfaction for diabetes care, diabetes medication use, and financial difficulties. Baseline data were collected in 114 pharmacies, where patients with T2D were…

No prominent works on this page.

  • Short-term impact of co-payment level increase on the use of medication and patient-reported outcomes in Finnish patients with type 2 diabetes

    Open Access•Piia Lavikainen, Emma Aarnio et al.•ARTICLE•Health Policy•2020

    A new reimbursement scheme for non-insulin medications used for treatment of hyperglycemia in type 2 diabetes (T2D) was implemented in Finland on January 1, 2017. The aim of the study was to evaluate the impact of this co-payment increase (i.e. + 35 percentage points) on patient-reported satisfaction for diabetes care, diabetes medication use, and financial difficulties. Baseline data were collected in 114 pharmacies, where patients with T2D were…

  • Normative values for paid and unpaid work productivity for estimating productivity-adjusted life expectancy in Finland

    Open Access•Piia Lavikainen, Jari Heiskanen et al.•ARTICLE•Social Science & Medicine•2026

    BACKGROUND: Normative regional estimates of productivity are essential for deriving reliable predictions of productivity-adjusted life expectancy (PALE). This study aimed to establish Finnish population norms for health-related productivity by estimating age- and sex-specific norms for paid and unpaid work productivity indices, as well as combined weighted productivity index. Using national life expectancy data, corresponding PALE values were als…

Diabetes mellitus (1 work) · Diabetes Treatment and Management (1 work) · Endocrinology (1 work) · Family medicine (1 work) · Global Health Care Issues (1 work) · Health care (1 work) · Health Systems, Economic Evaluations, Quality of Life (1 work) · Index (typography) (1 work) · Insulin (1 work) · Insurance, Mortality, Demography, Risk Management (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae